기업
CTCBIO, Leading company in incrementally modified drugs
바이오스펙테이터 Chon Seunghyun 기자
‘Leading incrementally modified drugs’, CTCBIO INC., love calls rush from both the domestic and the foreign pharmaceutical firms.
Since the establishment in 1993, starting as an animal medication sales company, CTCBIO has grown to become No. 1 in the domestic animal pharmaceutical market. But, recently they are expanding their business boundary to medication for human as well. They came up with a new type of incrementally modified drugs(IMD) that even the significant pharmacists struggled to create. Although what they developed isn’t so considered innovative, they clearly demonstrated their outstanding ability in developing new medical supplies of ‘unmet needs’, such as the world’s second premature ejaculation medicine and the world’s first film type Viagra generic.
There are constant demands from the top domestic pharmaceutics companies. As they made export contracts with leading multinational pharmaceutics companies (Ferring, Abbott, Teva, and more), CTCBIO is gradually receiving attention in the global market.
“We are not a company that makes new medications, but we are confident in our pharmaceutical manufacturing technology,” said Hong-Ryeol Jeon, the vice president of research and development at CTCBIO. “The amount of deposits given from the contracts made with global pharmaceutical companies proves the result of our research,” Jeon self-evaluated. CTCBIO received about 10 billion won from an export contract with Abbott since the end of last year.
◇ Leader of the film type medicines... The only pharmaceutical company licensed for film type medication in overseas market.
▲film type sildenafil generic 'please'... <계속>
